{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:47:08Z","timestamp":1791193628079,"version":"4.1.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[1983,6,1]],"date-time":"1983-06-01T00:00:00Z","timestamp":423273600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[1983,6,1]],"date-time":"1983-06-01T00:00:00Z","timestamp":423273600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Arch Toxicol"],"published-print":{"date-parts":[[1983,6]]},"DOI":"10.1007\/bf00302721","type":"journal-article","created":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T11:44:18Z","timestamp":1662119058000},"page":"107-141","source":"Crossref","is-referenced-by-count":129,"title":["Toxicological evaluation of cyclosporin A"],"prefix":"10.1007","volume":"53","author":[{"given":"B.","family":"Ryffel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Donatsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Mad\u00f6rin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. E.","family":"Matter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"R\u00fcttimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Stoll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF00302721_CR1","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1600-065X.1982.tb00412.x","volume":"63","author":"R Palacios","year":"1982","unstructured":"Palacios R (1982) Mechanism of T cell activation: Role and functional relationship of HLA-DR antigens and interleukins. Immunol Rev 63:73\u2013110","journal-title":"Immunol Rev"},{"key":"BF00302721_CR2","unstructured":"Hess AD, Tutschka PJ, Santos GW (1982) The effect of cyclosporin A on T lymphocyte subpopulations. In: Cyclosporin A, Proceed of Int Conf Elsevier\/North Holland Press, pp 209\u2013231"},{"key":"BF00302721_CR3","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/eji.1830110812","volume":"11","author":"D Bunjes","year":"1981","unstructured":"Bunjes D, Hardt C, R\u00f6llinghoff M, Wagner H (1981) CyclosporinA mediates immunosuppression of primary cytotoxic T cell response by impairing the release of interleukin 1 and interleukin 2. Eur J Immunol 11:657\u2013661","journal-title":"Eur J Immunol"},{"key":"BF00302721_CR4","doi-asserted-by":"crossref","unstructured":"Borel JF, Wiesinger D (1977) Effect of cyclosporin A on murine lymphoid cells. In: Regulatory mechanism in lymphocyte activation. Proceed 11th Leukocyte Culture. Conference AP, New York, pp 716\u2013718","DOI":"10.1016\/B978-0-12-458050-3.50139-9"},{"key":"BF00302721_CR5","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1016\/S0140-6736(78)91970-0","volume":"II","author":"RY Calne","year":"1978","unstructured":"Calne RY, Thiru S, McMaster P (1978) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet II:1323\u20131327","journal-title":"Lancet"},{"key":"BF00302721_CR6","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00007890-198111000-00002","volume":"32","author":"PJ Morris","year":"1981","unstructured":"Morris PJ (1981) Cyclosporin A, overview. Transplant 32:349\u2013354","journal-title":"Transplant"},{"key":"BF00302721_CR7","first-page":"57","volume":"II","author":"Multicenter Trial European","year":"1982","unstructured":"European Multicenter Trial (1982) Cyclosporin A as sole immunosuppressive agent in recipients of kidney allografts from cadaver donors. Lancet II:57\u201360","journal-title":"Lancet"},{"key":"BF00302721_CR8","volume-title":"Frontiers of Biology, vol 41","author":"JF Bach","year":"1975","unstructured":"Bach JF (1975) The mode of action of immunosuppressive agents. In: Frontiers of Biology, vol 41. North-Holland, Amsterdam"},{"key":"BF00302721_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/01971528108062989","volume":"2","author":"P Donatsch","year":"1981","unstructured":"Donatsch P, Abisch E, Hornberger M, Traber R, Trapp M, Voges R (1981) A radioimmunoassay to measure cyclosporin A in plasma and serum samples. J Immunoassay 2:19\u201332","journal-title":"J Immunoassay"},{"key":"BF00302721_CR10","volume-title":"Tumors of the mouse","author":"VS Turusov","year":"1979","unstructured":"Turusov VS (1979) Tumors of the mouse, IARC, vol 23. Lyon"},{"key":"BF00302721_CR11","volume-title":"Tumors of the rat","author":"VS Turusov","year":"1973","unstructured":"Turusov VS (1973) Tumors of the rat, IARC, vol 5. Lyon"},{"key":"BF00302721_CR12","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0165-7992(82)90039-2","volume":"105","author":"BE Matter","year":"1982","unstructured":"Matter BE, Donatsch P, Racine RR, Schmid B, Suter W (1982) Genotoxicity evaluation of Cyclosporin A, a new immunosuppressive agent. Mutat Res 105:257\u2013264","journal-title":"Mutat Res"},{"key":"BF00302721_CR13","unstructured":"Finney PJ (1971) Probit Analysis, 3rd Ed, Cambridge University Press"},{"key":"BF00302721_CR14","first-page":"624","volume":"5","author":"H Fink","year":"1965","unstructured":"Fink H, Hund G (1965) Arzneim Forsch\/Drug Res 5:624","journal-title":"Arzneim Forsch\/Drug Res"},{"key":"BF00302721_CR15","volume-title":"Statistische Auswertungsmethoden","author":"L Sachs","year":"1972","unstructured":"Sachs L (1972) Statistische Auswertungsmethoden. Springer, Berlin Heidelberg New York"},{"key":"BF00302721_CR16","unstructured":"Levene H (1960) Robust tests for equality of variances. In: Oklin I (ed) Contributions to probability and statistics. Essays in Honor of Harold Hotelling. Stanford, pp 278\u2013292"},{"key":"BF00302721_CR17","volume-title":"The design and analysis of experiments","author":"O Kempthorne","year":"1960","unstructured":"Kempthorne O (1960) The design and analysis of experiments. John Wiley, New York"},{"key":"BF00302721_CR18","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","volume":"50","author":"ChW Dunnett","year":"1955","unstructured":"Dunnett ChW (1955) A multiple comparison procedure for comparing several treatments with a control. J Am Stat Ass 50:1096\u20131121","journal-title":"J Am Stat Ass"},{"key":"BF00302721_CR19","volume-title":"Simultaneous statistical interference","author":"RG Miller","year":"1966","unstructured":"Miller RG (1966) Simultaneous statistical interference: McGraw Hill, New York"},{"key":"BF00302721_CR20","first-page":"719","volume":"22","author":"N Mantel","year":"1959","unstructured":"Mantel N and Haenszel LW (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719\u2013748","journal-title":"J Natl Cancer Inst"},{"key":"BF00302721_CR21","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/BF00427307","volume":"370","author":"BP Richardson","year":"1976","unstructured":"Richardson BP, Luginb\u00fchl H (1976) The role of prolactin in the development of chronic progressive nephropathy in the rat. Virchow's Arch A Pathol Anat Histol 370:13\u201319","journal-title":"Virchow's Arch A Pathol Anat Histol"},{"key":"BF00302721_CR22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1097\/00007890-198110000-00002","volume":"32","author":"AW Thomson","year":"1982","unstructured":"Thomson AW, Whiting PH, Blair JT, Davidson RJL, Simpson JG (1982) Pathological changes developing in the rat during a three week course of high dosage cyclosporin A and their reversal following drug withdrawal. Transplant 32:271\u2013277","journal-title":"Transplant"},{"key":"BF00302721_CR23","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/S0140-6736(81)91851-1","volume":"I","author":"GBG Klintmalm","year":"1981","unstructured":"Klintmalm GBG, Starzl TE, Iwatsuki S (1981) Nephrotoxicity of cyclosporin A in liver and kidney transplant patients. Lancet I:470\u2013471","journal-title":"Lancet"},{"key":"BF00302721_CR24","first-page":"1323","volume":"II","author":"RYC Calne","year":"1981","unstructured":"Calne RYC, White DIG, Thiru S (1981) Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet II:1323\u20131327","journal-title":"Lancet"},{"key":"BF00302721_CR25","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1016\/S0140-6736(81)92392-8","volume":"I","author":"DV Hamilton","year":"1981","unstructured":"Hamilton DV, Calne RY, Evans DB (1981) The effect of long-term Cyclosporin A on renal function. Lancet I:1218\u20131219","journal-title":"Lancet"},{"key":"BF00302721_CR26","unstructured":"Mihatsch MJ, Loertscher R, Spichtin HP (1982) Morphologic findings in kidney transplants after treatment with cyclosporin A. Clin Nephrol (in press)"},{"key":"BF00302721_CR27","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1056\/NEJM198112033052306","volume":"305","author":"H Shulman","year":"1981","unstructured":"Shulman H, Striker G, Deeg HJ (1981) Nephrotoxicity of Cyclosporin A after allogeneic marrow transplantation. New Engl J Med 305:1392\u20131395","journal-title":"New Engl J Med"},{"key":"BF00302721_CR28","doi-asserted-by":"crossref","first-page":"F1","DOI":"10.1152\/ajpcell.1981.241.1.C1","volume":"241","author":"GA Porter","year":"1981","unstructured":"Porter GA, Bennett WM (1981) Nephrotoxic acute renal failure due to common drugs. Am J Physiol 241:F1\u20138","journal-title":"Am J Physiol"},{"key":"BF00302721_CR29","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/S0140-6736(81)90320-2","volume":"II","author":"E Gluckman","year":"1981","unstructured":"Gluckman E, Devergie A, Lokiec E (1981) Cyclosporin A in bone-marrow transplantation. Lancet II:144\u2013145","journal-title":"Lancet"},{"key":"BF00302721_CR30","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1136\/bmj.285.6336.162","volume":"285","author":"AJ Barrett","year":"1982","unstructured":"Barrett AJ, Kendra JR (1982) Cyclosporin A prophylaxis of graft versus host disease in 36 patients. Br Med J 285:162\u2013166","journal-title":"Br Med J"},{"key":"BF00302721_CR31","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1016\/S0140-6736(78)91971-2","volume":"II","author":"RL Powles","year":"1978","unstructured":"Powles RL, Clink H, Sloane J (1978) Cyclosporin A for the treatment of graft-versus-host disease in man. Lancet II:1327\u20131331","journal-title":"Lancet"},{"key":"BF00302721_CR32","first-page":"1017","volume":"32","author":"JF Borel","year":"1977","unstructured":"Borel JF, Feuerer C, Magn\u00e9e C, St\u00e4helin H (1977) Effects of the new anti-lymphocytic peptide cyclosporin A in animals. Immunology 32:1017\u20131025","journal-title":"Immunology"},{"key":"BF00302721_CR33","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/279433a0","volume":"279","author":"MY Gordon","year":"1979","unstructured":"Gordon MY, Singer JW (1979) Selective effects of cyclosporin A on colony forming lymphoid and myeloid cells in man. Nature 279:433\u2013434","journal-title":"Nature"},{"key":"BF00302721_CR34","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S0140-6736(81)91816-X","volume":"II","author":"VE Von Fliedner","year":"1981","unstructured":"Von Fliedner VE, Grathwohl A (1981) Effect of cyclosporin A on immunological recovery after bone marrow transplantation. Lancet II:439","journal-title":"Lancet"},{"key":"BF00302721_CR35","unstructured":"Levy BM, Dreizen S, Bernick S (1979) In: Spontaneous animal models of human diseases. Volume 1, periodontal disease. Academic Press, pp 4\u201310"},{"key":"BF00302721_CR36","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/S0140-6736(79)92440-1","volume":"II","author":"RY Calne","year":"1979","unstructured":"Calne RY, Rolles K, Thiru S (1979) Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers. Lancet II:1033\u20131036","journal-title":"Lancet"},{"key":"BF00302721_CR37","doi-asserted-by":"crossref","first-page":"195","DOI":"10.14219\/jada.archive.1964.0038","volume":"68","author":"JR Babcock","year":"1964","unstructured":"Babcock JR (1964) Gingival hyperplasia and dilantin content of saliva: a pilot study. J Am Dent Assoc 68:195\u2013198","journal-title":"J Am Dent Assoc"},{"key":"BF00302721_CR38","first-page":"1988","volume":"19","author":"VC Chambers","year":"1970","unstructured":"Chambers VC, Evans CA (1970) Canine oral papillomatosis. Can Res 19:1988\u20131996","journal-title":"Can Res"},{"key":"BF00302721_CR39","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1097\/00007890-198011000-00017","volume":"30","author":"LC McIntosh","year":"1981","unstructured":"McIntosh LC, Thomson AW (1981) Activity of the mononuclearphagocyte system in cyclosporin A treated mice. Transplant 30:384\u2013386","journal-title":"Transplant"},{"key":"BF00302721_CR40","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/287542a0","volume":"287","author":"T Paavonen","year":"1980","unstructured":"Paavonen T, H\u00e4yry P (1980) Effect of cyclosporin A on T-dependent and T-independent immunoglobulin synthesis in vitro. Nature 287:542","journal-title":"Nature"},{"key":"BF00302721_CR41","unstructured":"IARC Monographs on the evaluation of the carcinogenic risk of chemicals to humans (1981) International Agency for research on cancer, vol 26"},{"key":"BF00302721_CR42","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00304023","volume":"79","author":"E Grundmann","year":"1973","unstructured":"Grundmann E, Hobik HP (1973) Lymphoretikul\u00e4re Sarkome bei immunologisch gesch\u00e4digten M\u00e4usen. Z Krebsforsch 79:298\u2013304","journal-title":"Z Krebsforsch"},{"key":"BF00302721_CR43","first-page":"359","volume":"13","author":"S Thiru","year":"1981","unstructured":"Thiru S, Calne RY (1981) Lymphomas in renal allograft patients treated with cyclosporin A as one of the immunosuppressive agents. Transplant Proc 13:359\u2013364","journal-title":"Transplant Proc"},{"key":"BF00302721_CR44","unstructured":"Borleffs JCC, Neuhaus P (1982) Cyclosporin A and Kidney transplantation in rhesus monkeys. In: Cyclosporin A, Proceed of Int Conf. Elsevier\/North Holland Press, pp 329\u2013342"},{"key":"BF00302721_CR45","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/bjc.1980.224","volume":"42","author":"SA Eccles","year":"1980","unstructured":"Eccles SA, Heckford SE, Alexander P (1980) Effect of cyclosporin A on the growth and spontaneous metastasis of syngeneic animal tumours. Br J Cancer 42:252\u2013259","journal-title":"Br J Cancer"},{"key":"BF00302721_CR46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(80)90579-6","volume":"I","author":"ChB Bieber","year":"1980","unstructured":"Bieber ChB, Reitz BA, Jamieson SW (1980) Malignant lymphoma in cyclosporin A treated allograft recipients. Lancet I:43","journal-title":"Lancet"},{"key":"BF00302721_CR47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/289300a0","volume":"289","author":"GA Bird","year":"1981","unstructured":"Bird GA, McLachlan SM, Britton S (1981) Cyclosporin A promotes spontaneous outgrowth in vitro of Epstein-Barr virus-induced B-cell lines. Nature 289:300\u2013301","journal-title":"Nature"},{"key":"BF00302721_CR48","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/j.1600-065X.1982.tb00425.x","volume":"65","author":"S Britton","year":"1982","unstructured":"Britton S, Palacios R (1982) Cyclosporin A-usefulness, risk and mechanism of action. Immunol Rev 65:5\u201322","journal-title":"Immunol Rev"},{"key":"BF00302721_CR49","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1016\/S0140-6736(82)90124-6","volume":"II","author":"H Siegl","year":"1982","unstructured":"Siegl H, Ryffel B (1982) Effect of cyclosporin on renin-angiotensin-aldosterone system. Lancet II:1274","journal-title":"Lancet"}],"container-title":["Archives of Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00302721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/BF00302721\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00302721.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T11:45:13Z","timestamp":1662119113000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/BF00302721"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1983,6]]},"references-count":49,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1983,6]]}},"alternative-id":["BF00302721"],"URL":"https:\/\/doi.org\/10.1007\/bf00302721","relation":{},"ISSN":["0340-5761","1432-0738"],"issn-type":[{"value":"0340-5761","type":"print"},{"value":"1432-0738","type":"electronic"}],"subject":[],"published":{"date-parts":[[1983,6]]}}}